These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 38181280)
21. Epidemiology of hand, foot and mouth disease in China, 2008 to 2015 prior to the introduction of EV-A71 vaccine. Yang B; Liu F; Liao Q; Wu P; Chang Z; Huang J; Long L; Luo L; Li Y; Leung GM; Cowling BJ; Yu H Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258646 [TBL] [Abstract][Full Text] [Related]
22. Hand, Foot, and Mouth Disease Caused by Coxsackievirus A6: A Preliminary Report from Istanbul. Ceylan AN; Turel O; Gultepe BS; Inan E; Turkmen AV; Doymaz MZ Pol J Microbiol; 2019; 68(2):165-171. PubMed ID: 31257789 [TBL] [Abstract][Full Text] [Related]
23. Virulence of Enterovirus A71 Fluctuates Depending on the Phylogenetic Clade Formed in the Epidemic Year and Epidemic Region. Kobayashi K; Nishimura H; Mizuta K; Nishizawa T; Chu ST; Ichimura H; Koike S J Virol; 2021 Nov; 95(23):e0151521. PubMed ID: 34523967 [TBL] [Abstract][Full Text] [Related]
24. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Mao Q; Wang Y; Bian L; Xu M; Liang Z Emerg Microbes Infect; 2016 Jul; 5(7):e75. PubMed ID: 27436364 [TBL] [Abstract][Full Text] [Related]
25. [Direct medical costs and influencing factors in severe hand, foot and mouth disease in children aged between six months and five years old]. Zheng YM; Yang J; Liao QH Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jan; 51(1):87-92. PubMed ID: 28056277 [No Abstract] [Full Text] [Related]
26. Outcomes following severe hand foot and mouth disease: A systematic review and meta-analysis. Jones E; Pillay TD; Liu F; Luo L; Bazo-Alvarez JC; Yuan C; Zhao S; Chen Q; Li Y; Liao Q; Yu H; Rogier van Doorn H; Sabanathan S Eur J Paediatr Neurol; 2018 Sep; 22(5):763-773. PubMed ID: 29778429 [TBL] [Abstract][Full Text] [Related]
27. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection. You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073 [TBL] [Abstract][Full Text] [Related]
28. [Hand-Foot-and-Mouth Disease, Aseptic Meningitis, and Encephalitis Caused by Enterovirus]. Fujimoto T Brain Nerve; 2018 Feb; 70(2):121-131. PubMed ID: 29433113 [TBL] [Abstract][Full Text] [Related]
29. Effectiveness of enterovirus A71 vaccine in severe hand, foot, and mouth disease cases in Guangxi, China. Jiang L; Wang J; Zhang C; He W; Mo J; Zeng J; Chen M; Tan Y; Ning C Vaccine; 2020 Feb; 38(7):1804-1809. PubMed ID: 31892446 [TBL] [Abstract][Full Text] [Related]
30. Surveillance for severe hand, foot, and mouth disease from 2009 to 2015 in Jiangsu province: epidemiology, etiology, and disease burden. Ji H; Fan H; Lu PX; Zhang XF; Ai J; Shi C; Huo X; Bao CJ; Shan J; Jin Y BMC Infect Dis; 2019 Jan; 19(1):79. PubMed ID: 30669973 [TBL] [Abstract][Full Text] [Related]
31. [Clinical characteristics and treatment assessments of severe enterovirus 71 infected children]. Liu JT; Peng D; Guan XH; Zou DD; Zhao DC Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):24-8. PubMed ID: 20441698 [TBL] [Abstract][Full Text] [Related]
32. Coxsackievirus B: The important agent of hand, foot, and mouth disease. Liu Y; Chen J; Zhang M; Guo W; Feng C; Liu J; Xu L; Gao N; Ma S J Med Virol; 2023 Mar; 95(3):e28669. PubMed ID: 36912377 [TBL] [Abstract][Full Text] [Related]
33. Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World. Gonzalez G; Carr MJ; Kobayashi M; Hanaoka N; Fujimoto T Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635198 [TBL] [Abstract][Full Text] [Related]
34. Current status of hand-foot-and-mouth disease. Zhu P; Ji W; Li D; Li Z; Chen Y; Dai B; Han S; Chen S; Jin Y; Duan G J Biomed Sci; 2023 Feb; 30(1):15. PubMed ID: 36829162 [TBL] [Abstract][Full Text] [Related]
35. [Continuous renal replacement therapy combined with extracorporeal membrane oxygenation for pediatric cardiopulmonary failure]. Zhou YP; Shi JY; Wang F; Cui Y; Xu TT; Wang CX; Zhang YC Zhonghua Er Ke Za Zhi; 2018 May; 56(5):336-341. PubMed ID: 29783818 [No Abstract] [Full Text] [Related]
36. [Clinical analysis of 555 outpatients with hand, foot and mouth diseases caused by different enteroviruses]. Cui P; Li Y; Zhou CC; Zhou YH; Song CL; Qiu Q; Wang F; Guo C; Han SJ; Liang L; Yuan Y; Zeng MY; Yue J; Long L; Qin XH; Li Z; Chen XL; Zou YP; Cheng YB; Yu HJ Zhonghua Er Ke Za Zhi; 2019 Jun; 57(6):445-451. PubMed ID: 31216802 [No Abstract] [Full Text] [Related]
37. Recent advances in enterovirus A71 pathogenesis: a focus on fatal human enterovirus A71 infection. Xing J; Wang K; Wang G; Li N; Zhang Y Arch Virol; 2022 Dec; 167(12):2483-2501. PubMed ID: 36171507 [TBL] [Abstract][Full Text] [Related]
39. Type I Interferon-Induced TMEM106A Blocks Attachment of EV-A71 Virus by Interacting With the Membrane Protein SCARB2. Guo X; Zeng S; Ji X; Meng X; Lei N; Yang H; Mu X Front Immunol; 2022; 13():817835. PubMed ID: 35359978 [TBL] [Abstract][Full Text] [Related]
40. Research progress on pathogenic and therapeutic mechanisms of Enterovirus A71. Lai J; Li Z; Pan L; Huang Y; Zhou Z; Ma C; Guo J; Xu L Arch Virol; 2023 Sep; 168(10):260. PubMed ID: 37773227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]